Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infectious agents : current concepts and perspectives].

J Pijck, A Vuye

    Annales De Biologie Clinique
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of Spectrum-10 system for identification of members of the family Enterobacteriaceae.

    Journal of clinical microbiology·1989
    Same author

    Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

    Antimicrobial agents and chemotherapy·1989
    Same author

    Investigation of the ability of newer beta-lactam antibiotics to select resistant mutants from Serratia marcescens after mutagenesis with nitrosoguanidine.

    Arzneimittel-Forschung·1989
    Same author

    Bioluminescence Assay for Measuring the Number of Bacteria Adhering to the Hydrocarbon Phase in the BATH Test.

    Applied and environmental microbiology·1988
    Same author

    Transferable resistance to ceftazidime in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

    Acta clinica Belgica·1988
    Same author

    Reactualisation of the in vitro activity of tetracycline antibiotics.

    Acta clinica Belgica·1988
    Same journal

    [The role of the heart-on-a-chip to drug evaluation].

    Annales de biologie clinique·2026
    Same journal

    A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

    Annales de biologie clinique·2026
    Same journal

    Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

    Annales de biologie clinique·2026
    Same journal

    Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

    Annales de biologie clinique·2026
    Same journal

    [Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

    Annales de biologie clinique·2026
    Same journal

    [Summary of the 34th National Conference of the National College of Hospital Biochemistry].

    Annales de biologie clinique·2026
    See all related articles

    Antimicrobial resistance necessitates novel strategies, including new drugs and improved vaccines. This research explores future infectious disease challenges and potential therapeutic and immunological solutions.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pharmacology
    • Immunology

    Context:

    • Emerging infectious diseases and unknown syndromes pose significant public health challenges.
    • Antimicrobial resistance is a growing threat, requiring innovative treatment approaches.
    • Advancements in immunology offer new avenues for disease prevention and diagnosis.

    Purpose:

    • To discuss the future development of infectious agents and antimicrobial strategies.
    • To explore novel chemotherapy approaches, including new products and enzyme inhibitors.
    • To review recent progress and future prospects in vaccine development and immunological identification techniques.

    Summary:

    • The paper details emerging infectious agents and microbial etiologies of rare syndromes.

    Related Experiment Videos

  • It outlines key chemotherapy developments: novel agents, microbial enzyme inhibitors, and targeted drug delivery.
  • The authors emphasize optimizing current antimicrobial drug use and highlight advances in vaccines and immunological diagnostics.

    • Impact:

    • Provides a forward-looking perspective on combating infectious diseases.
    • Informs the development of next-generation antimicrobial therapies and vaccines.
    • Highlights the critical role of both chemotherapy and immunology in future infectious disease management.